Sodium-Glucose Cotransporter 2 Inhibitors and Diabetic Ketoacidosis: A Case Series From Three Academic Institutions.

Autor: Misaghian-Xanthos N; University of North Carolina School of Medicine, Chapel Hill, NC., Shariff AI; Duke University School of Medicine, Durham, NC., Mekala K; Wake Forest School of Medicine, Winston-Salem, NC., Fearrington LR; University of North Carolina School of Medicine, Chapel Hill, NC., Setji TL; Duke University School of Medicine, Durham, NC., Aloi JA; Wake Forest School of Medicine, Winston-Salem, NC., Buse JB; University of North Carolina School of Medicine, Chapel Hill, NC jbuse@med.unc.edu.
Jazyk: angličtina
Zdroj: Diabetes care [Diabetes Care] 2017 Jun; Vol. 40 (6), pp. e65-e66. Date of Electronic Publication: 2017 Mar 28.
DOI: 10.2337/dc16-2591
Databáze: MEDLINE